Molecular Biology Enzymes, Reagents, and Kits Market 2031
Molecular Biology Enzymes, Reagents, and Kits Market 2031
Segments - Molecular Biology Enzymes, Reagents, and Kits Market by Product (Enzymes and Kits & Reagents), Application (Restriction Digestion, PCR, Cloning, Sequencing, Epigenetics, and Others), End-user (Hospital & Diagnostics, Pharma & Biotech, Academic & Research, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5790
| 2.8 Rating
| 54 Reviews
| 199 Pages
| Format :
Report Description
Molecular Biology Enzymes, Reagents, and Kits Market Outlook 2031
The global molecular biology enzymes, reagents, and kits market size was valued at USD 20.4 billion in 2023 and is likely to reach USD 47.6 billion by 2031, expanding at a CAGR of 9.83% during 2023 – 2031. The growth of the market is attributed to the ongoing research in genetics and molecular biology.
Increasing elderly population is resulting in rising demand for enzymes, reagents, and kits used in molecular biology research and applications. Molecular biology tools are important for studying the genetic and molecular mechanisms underlying diseases. This research helps to develop targeted therapies and interventions to improve the quality of life for elderly people.
-
According to the report published by the World Health Organization (WHO) on October 1, 2022, around 1 in 6 people across the globe is projected to be aged 60 years or over by 2030. Furthermore, the population aged 60 years and above is expected to increase from 1 billion in 2020 to 1.4 billion by 2050.
Molecular biology enzymes, reagents, and kits are fundamental tools used in the field of molecular biology to manipulate and study DNA, RNA, and proteins. Enzymes are specialized biological catalysts that facilitate essential processes, such as DNA replication, transcription, and protein synthesis.
Reagents encompass a wide range of chemical substances, including buffers, salts, and dyes, used to optimize experimental conditions and react with biomolecules. On the other hand, kits are pre-packaged sets of enzymes, reagents, and instructions designed to perform specific experiments or procedures.
The COVID-19 pandemic boosted the market. The need for virus testing, both for diagnosis and monitoring, led to a surge in demand for PCR reagents and other essential components used in testing kits. Furthermore, the rapid development of COVID-19 vaccines increased their demand and fueled the market during the pandemic.
Impact of Artificial Intelligence (AI) on Molecular Biology Enzymes, Reagents, and Kits Market
Emergence of artificial intelligence is expected to propel the market. This technology helps researchers to interpret complex biological data and contribute to the development of innovative kits and reagents. Additionally, machine learning algorithms are aiding in the identification of potential drug targets and the optimization of enzyme and kit manufacturing.
Molecular Biology Enzymes, Reagents, and Kits Market Dynamics
Major Drivers
Growing burden of infectious diseases is expected to drive the market. The COVID-19 pandemic has highlighted the need for advanced diagnostic tools. Molecular biology tools, including enzymes, reagents, and kits, are crucial for the rapid and accurate identification of pathogens. Moreover, they facilitate early detection, containment, and treatment of infectious diseases. Thus, the rising infectious diseases contribute to the growth of the market.
-
According to a report published by the Centers for Disease Control and Prevention on September 19, 2023, around 3.8 million people in the US visited the emergency department and received a primary diagnosis for infectious and parasitic diseases in 2021.
Existing Restraints
Limited reimbursements for genetic testing are expected to hinder the market. This makes genetic testing financially burden some and reduces the accessibility of these tests. Thus, few people opt for genetic testing.This, in turn, diminishes the demand for the tools and materials used in molecular biology. Additionally, high costs associated with advanced molecular biology tools further hamper the market.
Emerging Opportunities
Increasing investments in research and development (R&D) are expected to create immense opportunities for the players competing in the market. Manufacturers are exploring and developing enzymes, reagents, and kits with improved performance and enhanced efficiency. Furthermore, advancement in these tools to meet the specific requirements of researchers and diagnostic laboratories is boosting the market.
Scope of the Molecular Biology Enzymes, Reagents, and Kits Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Molecular Biology Enzymes, Reagents, and Kits Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product (Enzymes and Kits & Reagents), Application (Restriction Digestion, PCR, Cloning, Sequencing, Epigenetics, and Others), and End-user (Hospital & Diagnostics, Pharma & Biotech, Academic & Research, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Agilent Technologies, Inc; Bio-Rad Laboratories, Inc; F. Hoffmann-La Roche Ltd; Illumina, Inc; Merck KGaA; New England Biolabs; Promega Corporation; QIAGEN; and Thermo Fisher Scientific, Inc |
Molecular Biology Enzymes, Reagents, and Kits Market Segment Insights
Product Segment Analysis
Based on product, the molecular biology enzymes, reagents, and kits market is bifurcated into enzymes and kits & reagents. The kits & reagents segment is expected to hold a major market share during the forecast period, as they are convenient and time-efficient solutions for researchers and scientists. Kits & reagents are pre-packaged with all the necessary components in precise quantities, which reduces the time and effort required for the preparation of molecular biology experiments. Moreover, continuous product launches from the major market player are further propelling the market.
-
On February 09, 2023, PerkinElmer, Inc, a global medical technology developer, announced the launch of their NEXTFLEX Variant-Seq SARS-CoV-2 kit v2 and software solutions. This innovative technology reduces the turnaround time by three hours by eliminating the need for individual library quantification before the pooling process.
The enzymes segment is expected to expand at a considerable CAGR in the coming years, owing to their high adoption to accelerate biological reactions, such as DNA replication, transcription, and translation. These processes are fundamental to various applications, including gene cloning, sequencing, and protein expression. Enzymes facilitate these reactions, making them indispensable in research and diagnostics. Moreover, increasing utilization of enzymes in gene editing technologies boost the market.
Application Segment Analysis
On the basis of application,the market is classified as restriction digestion, PCR, cloning, sequencing, epigenetics, and others. The sequencing segment is anticipated to register robust growth,due to the rising adoption of sequencing-based personalized medicinal treatment in oncology. This approach helps in identifying genetic predispositions, selecting effective therapies, and avoiding adverse reactions to medications. Additionally, major players in the sequencing technology industry are implementing various strategies, which further propel the segment.
The PCR segment is projected to expand at a considerable CAGR during the projected period, due to the increasing demand for real-time detection kits for virus diagnosis. PCRhas the ability to diagnose diseases by detecting DNA or RNA from pathogens, such as viruses or bacteria. It is essential for diagnosing infectious diseases, including COVID-19, genetic disorders, and cancer. Furthermore, PCR helps in the timely treatment and control of disease, due to its accurate and rapid diagnostic capabilities,thereby fueling the segment.
End-user Segment Analysis
In terms of end-user, the molecular biology enzymes, reagents, and kits market is fragmented into hospital & diagnostics, pharma & biotech, academic & research, and others. The pharma & biotech segment is expected to hold a key market share during the projected period, due to thegrowing utilization of molecular biology tools in innovative drugs and biotech solutions.
Enzymes, reagents, and kits are essential for understanding disease mechanisms, identifying drug targets, and screening potential compounds. These processesare foundational for developing new medications. Furthermore, a rising number of clinical studies to assess drug efficacy and safety boosts the demand for molecular biology tools, including biotechnology reagents and kits.
-
According to the report published on May 31, 2023, an estimated 454,000 clinical studies were registered across the globe as of May 2023,which shows an increase of 16,270 studies compared to previous years 2022.
The academic & research segment is projected to grow at a significant pace during the forecast period,as academic & research institutes heavily rely on kits and reagents to conduct their experiments and investigations. Molecular biology tools are essential for these institutions to conduct experiments and develop novel treatments.
Regional Outlook
In terms of region, the global molecular biology enzymes, reagents, and kits market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market in the coming years, due to thewell-established pharmaceutical and biotechnology industry. These companies heavily rely on molecular biology tools for drug discovery, biologics development, and clinical trials. Furthermore, the increasing number of populations suffering from chronic diseases propels the market.
-
According to the report published by the National Association of Chronic Diseases Directors,approximately 40% of individuals in the US suffered from multiple chronic conditions in 2022.
The market in Asia Pacific is anticipated to expand at a rapid pace during the projection period, due to the rapidly growing population and rising demand for targeted therapies. This demographic shift led to increasing utilization of kits, enzymes, and reagents. Moreover, increasing investments in healthcare, biotechnology, and research boost the demand for molecular biology tools.
Segments
The global molecular biology enzymes, reagents, and kits market has been segmented on the basis of
Product
- Enzymes
- Kits & Reagents
Application
- Restriction Digestion
- PCR
- Cloning
- Sequencing
- Epigenetics
- Others
End-user
- Hospital & Diagnostics
- Pharma & Biotech
- Academic & Research
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Agilent Technologies, Inc
- Bio-Rad Laboratories, Inc
- F. Hoffmann-La Roche Ltd
- Illumina, Inc
- Merck KGaA
- New England Biolabs
- Promega Corporation
- QIAGEN
- Thermo Fisher Scientific, Inc
Competitive Landscape
Key players competing in the global molecular biology enzymes, reagents, and kits market are Agilent Technologies, Inc; Bio-Rad Laboratories, Inc; F. Hoffmann-La Roche Ltd; Illumina, Inc; Merck KGaA; New England Biolabs; Promega Corporation; QIAGEN; and Thermo Fisher Scientific, Inc.
These companies are expanding their market share by implementing various strategies, such as partnerships, acquisitions, mergers, launching new products, and implementing advanced AI technologies.
-
On May 22, 2023, QIAGEN,a multinational provider of technologies for molecular diagnostics, made its high-standard enzymes available as individual products. This allows industrial customers and researchers worldwide to customize their assays and workflows.
-
On November 25, 2021, Novozymes, a multinational biotechnology company, announced its strategic collaboration agreement with Novo Nordisk A/S, a Denmark-based multinational pharmaceutical company. The companies are joined to develop top-notch technical enzymes to accelerate the manufacturing process in the biopharmaceutical sector.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Biology Enzymes, Reagents & Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molecular Biology Enzymes, Reagents & Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molecular Biology Enzymes, Reagents & Kits Market - Supply Chain
4.5. Global Molecular Biology Enzymes, Reagents & Kits Market Forecast
4.5.1. Molecular Biology Enzymes, Reagents & Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molecular Biology Enzymes, Reagents & Kits Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Molecular Biology Enzymes, Reagents & Kits Market Absolute $ Opportunity
5. Global Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
5.3.1. Restriction Digestion
5.3.2. PCR
5.3.3. Cloning
5.3.4. Sequencing
5.3.5. Epigenetics
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
6.3.1. Hospital & Diagnostics
6.3.2. Pharma & Biotech
6.3.3. Academic & Research
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
8. North America Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
8.4.1. Restriction Digestion
8.4.2. PCR
8.4.3. Cloning
8.4.4. Sequencing
8.4.5. Epigenetics
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
8.7.1. Hospital & Diagnostics
8.7.2. Pharma & Biotech
8.7.3. Academic & Research
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
9. Latin America Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
9.4.1. Restriction Digestion
9.4.2. PCR
9.4.3. Cloning
9.4.4. Sequencing
9.4.5. Epigenetics
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
9.7.1. Hospital & Diagnostics
9.7.2. Pharma & Biotech
9.7.3. Academic & Research
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
10. Europe Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
10.4.1. Restriction Digestion
10.4.2. PCR
10.4.3. Cloning
10.4.4. Sequencing
10.4.5. Epigenetics
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
10.7.1. Hospital & Diagnostics
10.7.2. Pharma & Biotech
10.7.3. Academic & Research
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
11. Asia Pacific Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
11.4.1. Restriction Digestion
11.4.2. PCR
11.4.3. Cloning
11.4.4. Sequencing
11.4.5. Epigenetics
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
11.7.1. Hospital & Diagnostics
11.7.2. Pharma & Biotech
11.7.3. Academic & Research
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
12. Middle East & Africa Molecular Biology Enzymes, Reagents & Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by Applications
12.4.1. Restriction Digestion
12.4.2. PCR
12.4.3. Cloning
12.4.4. Sequencing
12.4.5. Epigenetics
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Molecular Biology Enzymes, Reagents & Kits Market Size and Volume Forecast by End Users
12.7.1. Hospital & Diagnostics
12.7.2. Pharma & Biotech
12.7.3. Academic & Research
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Molecular Biology Enzymes, Reagents & Kits Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Molecular Biology Enzymes, Reagents & Kits Market: Market Share Analysis
13.2. Molecular Biology Enzymes, Reagents & Kits Distributors and Customers
13.3. Molecular Biology Enzymes, Reagents & Kits Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Agilent Technologies, Inc
13.4.2. Bio-Rad Laboratories, Inc
13.4.3. F. Hoffmann-La Roche Ltd
13.4.4. Illumina, Inc
13.4.5. Merck KGaA
13.4.6. New England Biolabs
13.4.7. Promega Corporation
13.4.8. QIAGEN
13.4.9. Thermo Fisher Scientific, Inc
Methodology
Related Reports
Some other reports from this category!
Our Clients
